Published in J Clin Endocrinol Metab on April 29, 2008
2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J (2014) 1.73
Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol (2012) 0.98
Subclinical hypothyroidism in children: normal variation or sign of a failing thyroid gland? Int J Pediatr Endocrinol (2010) 0.96
DUOX2 Mutations Are Frequently Associated With Congenital Hypothyroidism in the Korean Population. Ann Lab Med (2016) 0.94
Congenital hypothyroidism. Indian J Endocrinol Metab (2015) 0.93
Transient congenital hypothyroidism. Indian J Endocrinol Metab (2011) 0.92
Update on some aspects of neonatal thyroid disease. J Clin Res Pediatr Endocrinol (2010) 0.87
Prevalence of permanent congenital hypothyroidism in isfahan-iran. Int J Prev Med (2013) 0.85
Screening for congenital hypothyroidism: comparison of borderline screening cut-off points and the effect on the number of children treated with levothyroxine. Eur Thyroid J (2013) 0.84
Genetic analysis in children with transient thyroid dysfunction or subclinical hypothyroidism detected on neonatal screening. Clin Pediatr Endocrinol (2009) 0.81
Subclinical hypothyroidism in childhood - current knowledge and open issues. Nat Rev Endocrinol (2016) 0.78
Non-autoimmune subclinical hypothyroidism due to a mutation in TSH receptor: report on two brothers. Ital J Pediatr (2013) 0.78
Subclinical hypothyroidism in children. Indian J Endocrinol Metab (2012) 0.78
The Role of Thyrotropin-Releasing Hormone Stimulation Test in Management of Hyperthyrotropinemia in Infants. J Clin Res Pediatr Endocrinol (2015) 0.75
Newborn screening for congenital hypothyroidism: improved assay performance has created an evidence gap. J Inherit Metab Dis (2010) 0.75
Growth and specialized growth charts of children with congenital hypothyroidism detected by neonatal screening in isfahan, iran. ISRN Endocrinol (2013) 0.75
Performance metrics after changes in screening protocol for congenital hypothyroidism. Pediatrics (2012) 0.75
Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision). Clin Pediatr Endocrinol (2015) 0.75
Diabetes and cancer. Endocr Relat Cancer (2009) 5.04
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev (2009) 3.53
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol (2013) 2.80
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab (2004) 2.71
The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem (2008) 2.20
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem (2002) 2.15
Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. J Clin Endocrinol Metab (2013) 1.86
Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst (2009) 1.80
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab (2010) 1.79
Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway. Endocrinology (2012) 1.69
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer Res (2005) 1.58
The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev (2008) 1.52
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab (2002) 1.44
Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism (2002) 1.40
Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev (2013) 1.39
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res (2009) 1.37
Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab (2002) 1.32
Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol (2013) 1.31
Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab (2004) 1.30
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology (2006) 1.23
Risk factors for congenital hypothyroidism: results of a population case-control study (1997-2003). Eur J Endocrinol (2005) 1.22
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One (2011) 1.22
HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res (2006) 1.16
Thyroid hemiagenesis: prevalence in normal children and effect on thyroid function. J Clin Endocrinol Metab (2003) 1.14
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene (2002) 1.12
A variation in 3' UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet (2002) 1.05
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization. J Clin Endocrinol Metab (2008) 1.05
Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. J Biol Chem (2003) 1.04
Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. Endocrinology (2003) 1.01
An ATG repeat in the 3'-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab (2002) 1.00
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. J Clin Endocrinol Metab (2011) 0.99
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells. Breast Dis (2003) 0.99
Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. J Clin Endocrinol Metab (2009) 0.98
High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) (2005) 0.97
Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology (2012) 0.96
Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A. Endocrinology (2009) 0.96
Diabetes: diabetes therapy and cancer risk. Nat Rev Endocrinol (2009) 0.93
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Endocrinology (2004) 0.91
Research resource: New and diverse substrates for the insulin receptor isoform A revealed by quantitative proteomics after stimulation with IGF-II or insulin. Mol Endocrinol (2011) 0.91
Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling. J Biol Chem (2007) 0.91
Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer (2002) 0.91
Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function. J Biol Chem (2003) 0.91
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells. Cancer Res (2007) 0.90
Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells. Cancer Res (2009) 0.90
A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid (2011) 0.90
Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. Diabetes Metab Res Rev (2015) 0.90
Intragastric balloon in association with lifestyle and/or pharmacotherapy in the long-term management of obesity. Obes Surg (2012) 0.88
The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer (2005) 0.87
p73 tumor-suppressor activity is impaired in human thyroid cancer. Cancer Res (2003) 0.87
Reactivation of p53 mutants by prima-1 [corrected] in thyroid cancer cells. Int J Cancer (2011) 0.87
Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. J Clin Endocrinol Metab (2013) 0.86
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. Thyroid (2014) 0.85
Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor". Front Endocrinol (Lausanne) (2013) 0.85
HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene. Eur J Cancer (2010) 0.83
Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease. J Clin Endocrinol Metab (2013) 0.83
Insulin analogs and cancer. Front Endocrinol (Lausanne) (2012) 0.83
Selective insulin receptor modulators (SIRM): a new class of antidiabetes drugs? Diabetes (2012) 0.83
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells. Int J Cancer (2009) 0.82
Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease. J Clin Endocrinol Metab (2004) 0.82
Secular trends in the prevalence of overweight and obesity in Sicilian schoolchildren aged 11-13 years during the last decade. PLoS One (2012) 0.82
Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Diabetes Care (2006) 0.82
High prevalence of overweight and obesity in 11-15-year-old children from Sicily. Nutr Metab Cardiovasc Dis (2006) 0.81
IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding. Ann N Y Acad Sci (2004) 0.81
Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease. Acta Diabetol (2013) 0.81
Levels of histone acetylation in thyroid tumors. Biochem Biophys Res Commun (2011) 0.80
Graves' orbitopathy: extraocular muscle/total orbit area ratio is positively related to the Clinical Activity Score. Eur J Ophthalmol (2012) 0.80
Severe Graves' ophthalmopathy after percutaneous ethanol injection in a nontoxic thyroid nodule. Thyroid (2011) 0.80
GABA(A) receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology (2005) 0.79
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation. Mol Cancer Res (2008) 0.79
Genetics of specific phenotypes of congenital hypothyroidism: a population-based approach. Thyroid (2002) 0.79
False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs. J Nucl Med (2002) 0.78
Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking α-lipoic acid. Clin Endocrinol (Oxf) (2013) 0.78
Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway. Ann N Y Acad Sci (2009) 0.78
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway. J Clin Endocrinol Metab (2013) 0.78
Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup. Thyroid (2004) 0.77
Basal insulin and cardiovascular and other outcomes. N Engl J Med (2012) 0.77
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression. J Cell Physiol (2014) 0.77
Cardiac arrest after intravenous calcium administration for calcitonin stimulation test. Thyroid (2013) 0.77
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription. Cell Oncol (Dordr) (2011) 0.76
Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2009) 0.76
The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Clin Endocrinol (Oxf) (2003) 0.75
Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260. Diabetes (2010) 0.75
The antiepileptic drug carbamazepine can cause adrenal insufficiency in patients under hormone replacement therapy for congenital adrenal hyperplasia. Hormones (Athens) (2013) 0.75